Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

74 results
Display

Bi-segmentectomy versus wedge hepatic resection in extended cholecystectomy for T2 and T3 gallbladder cancer: A matched case-control study

Nag HH, Nekarakanti PK, Sachan A, Nabi P, Tyagi S

Backgrounds/Aims: Extended cholecystectomy (EC) is the mainstay of treatment in most patients with potentially curable gallbladder cancer (GBC). The optimum extent of hepatic resection in EC is debatable. Methods: This retrospective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is percutaneous destruction of a solitary liver colorectal metastasis as effective as a resection?

Marchese U, Seux H, Garnier J, Ewald J, Piana G, Lelong B, Chaisemartin CD, Meillat H, Delpero JR, Turrini O

Backgrounds/Aims: Surgical resection remains the gold standard in the treatment of colorectal liver metastasis. However, when a patient presents with a deep solitary colorectal liver metastasis (S-CLM), the balance between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Value of surgical resection compared to transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein tumor thrombus: A meta-analysis of hazard ratios from five observational studies

Kang K, Song SK, Chung CW, Park Y

Backgrounds/Aims: Although systemic therapy is recommended in advanced hepatocellular carcinoma (HCC), treatment options for advanced HCC with portal vein tumor thrombosis (PVTT) are debatable. Recent studies have recommended other treatments,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is the anatomical resection necessary for single hepatocellular carcinoma smaller than 3 cm?: single-center experience of liver resection for a small HCC

Shin S, Kim TS, Lee JW, Ahn KS, Kim YH, Kang KJ

BACKGROUNDS/AIMS: The superiority of anatomical resection (AR) for a small HCC remains controversial. In this study, we investigated the clinical outcomes after AR and non-anatomical liver resection (NAR) for single...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation

Chung YK, Hwang S, Song GW, Lee YJ, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Ryoo BY, Lee SG

BACKGROUNDS/AIMS: Hepatocellular carcinoma (HCC) recurrence following hepatic resection (HR) and liver transplantation (LT) remains a great concern. We assessed the antitumor effects of metformin in patients treated with sorafenib for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in the types of liver diseases requiring hepatic resection: a single-institution experience of 9016 cases over a 10-year period

Cho HD, Hwang S, Lee YJ, Park KM, Kim KH, Kim JC, Ahn CS, Moon DB, Ha TY, Lee SG

BACKGROUNDS/AIMS: To understand the changing demands for hepatic resection (HR), we collected data regarding HR performed in a tertiary centre over a period of 10 years. METHODS: We carried out extensive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH

BACKGROUND/AIMS: Treating hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) remains controversial. We compared the outcomes of hepatic resection (HR), transarterial chemoembolization (TACE), and sorafenib therapy as treatments for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma

Lee IJ, Kim JW, Han KH, Kim JK, Kim KS, Choi JS, Park YN, Seong J

PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment. After shrinkage of tumors in selected patients, surgical resection is performed. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of metabolic and other clinicopathologic factors on the prognosis of patients with hepatocellular carcinoma undergoing hepatic resection

Choi KS, Kim DS, Jung SW, Yu YD, Suh SO

BACKGROUNDS/AIMS: The prognosis of hepatic resection for hepatocellular carcinoma (HCC) in patients with cirrhosis is worse than in those without cirrhosis. In Korea, the hepatitis B virus prevalence rate is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases

Park MS, Yi NJ, Son SY, You T, Suh SW, Choi YR, Kim H, Hong G, Lee KB, Lee KW, Jeong SY, Park KJ, Suh KS, Park JG

PURPOSE: Hepatic resection is a standard method of treatment for colorectal liver metastases (CRLM). However, the pathologic factors of metastatic lesions that affect tumor recurrence are less well defined in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience

Park SK, Jung YK, Chung DH, Kim KK, Park YH, Lee JN, Kwon OS, Kim YS, Choi DJ, Kim JH

BACKGROUND/AIMS: Recurrence after hepatic resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). We identified prognostic factors affecting overall survival...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Radiofrequency Ablation and Resection for Hepatic Metastasis from Colorectal Cancer

Lee KH, Kim HO, Yoo CH, Son BH, Park YL, Cho YK, Kim H, Han WK

BACKGROUND/AIMS: Radiofrequency ablation (RFA) has been mostly used as a therapeutic alternative to hepatic resection for treating liver metastasis of colorectal cancer. The purpose of the present study was to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?

Son SY, Yi NJ, Hong G, Kim H, Park MS, Choi YR, Suh KS, Kim DW, Jeong SY, Park KJ, Park JG, Lee KU

BACKGROUNDS/AIMS: Hepatic resection has only guaranteed long-term survival in patients with colorectal liver metastasis (CRLM) even in the era of effective chemotherapy. The definite role of neoadjuvant chemotherapy (NCT) is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Scoring of prognostic factors that influence long-term survival in patients with hepatic metastasis of colorectal cancer

Ahn SW, Na AS, Yang JD, Hwang HP, Yu HC, Cho BH

BACKGROUNDS/AIMS: To find independent predictors that affect the survival in patients with hepatic metastasis of colorectal cancer after surgery and to devise a risk scoring system. METHODS: Among 150 patients who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatic Resection in Patients with Hepatocellular Carcinoma Accompanied by Portal Vein Thrombus

Jung SM, Ahn CS, Lee SG, Lee YJ, Park KM, Hwang S, Kim KH, Moon DB, Ha TY

  • KMID: 1449802
  • Korean J Hepatobiliary Pancreat Surg.
  • 2011 Feb;15(1):19-27.
PURPOSE: Although surgical resection is the most effective treatment for hepatocellular carcinoma (HCC) accompanied by portal vein tumor thrombus (PVTT), the recurrence rate is very high and prognosis is poor....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcome of Hepatic Resection for Hepatocellular Carcinoma within the Milan Criteria in Child-Pugh Class A Patients

Kim KH, Kim JS, Park JI, Kim KH, Choi CS, Choi YK

PURPOSE: Hepatic resection and liver transplantation are considered a curative treatment for hepatocellular carcinoma (HCC) within the Milan criteria. In this study, we examine the outcome of hepatic resection for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcomes of a Hepatic Resection for Colorectal-Carcinoma Liver Metastases

Lee WK, Kim SB, Cho EH, Hwang DY, Moon SM

PURPOSE: Recent managements of liver metastasis from colorectal cancer consist of multi-disciplinary treatments. Although hepatic resection is the only curative treatment, for which long-term survival is expected, the recurrence rates...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of Spontaneous Bacterial Peritonitis after Extended Hepatic Resection in a Patient without Evidence of Liver Cirrhosis

Kwak MS, Lee JH, Kim YJ, Yoon JH, Lee HS

  • KMID: 2167220
  • Gut Liver.
  • 2010 Mar;4(1):129-134.
Hilar cholangiocarcinomas are often treated with liver resections. Hepatic dysfunction and infection are common postoperative complications. Although secondary bacterial peritonitis due to abdominal abscess or perforation is common, we report...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size

Choi SB, Kim KS, Park YN, Choi JS, Lee WJ, Seong J, Han KH, Lee JT

In cases of large hepatocellular carcinoma (HCC), neoadjuvant treatment such as transarterial chemoembolization (TACE) and radiation therapy can be performed. The aim of this study was to evaluate the outcome...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatic Resection in Patients with Liver Metastasis from Gastric Cancer

Jun KH, Chin HM

  • KMID: 2372932
  • J Korean Gastric Cancer Assoc.
  • 2009 Mar;9(1):14-17.
The clinical significance of hepatic resection for gastric metastases is controversial, even though hepatic resection has been widely accepted as a modality for colorectal metastases. Very few patients with gastric...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr